agilon health (NYSE:AGL) Cut to “Market Perform” at JMP Securities

JMP Securities downgraded shares of agilon health (NYSE:AGLFree Report) from an outperform rating to a market perform rating in a research note released on Monday, MarketBeat.com reports.

AGL has been the topic of several other reports. Benchmark restated a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. Evercore ISI reduced their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Finally, William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $6.38.

Get Our Latest Stock Analysis on agilon health

agilon health Price Performance

Shares of AGL opened at $1.72 on Monday. The company has a market capitalization of $708.67 million, a P/E ratio of -2.01 and a beta of 0.60. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. The firm has a 50 day moving average of $3.14 and a 200 day moving average of $4.90. agilon health has a twelve month low of $1.70 and a twelve month high of $13.76.

agilon health (NYSE:AGLGet Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. During the same quarter in the prior year, the business posted ($0.06) EPS. As a group, equities research analysts anticipate that agilon health will post -0.35 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of hedge funds have recently modified their holdings of AGL. Quantbot Technologies LP acquired a new stake in agilon health during the first quarter worth about $862,000. Swiss National Bank increased its position in agilon health by 0.6% during the first quarter. Swiss National Bank now owns 602,800 shares of the company’s stock worth $3,677,000 after purchasing an additional 3,400 shares during the last quarter. Bleakley Financial Group LLC acquired a new stake in agilon health during the first quarter worth about $65,000. Blair William & Co. IL increased its position in agilon health by 8.3% during the first quarter. Blair William & Co. IL now owns 242,076 shares of the company’s stock worth $1,477,000 after purchasing an additional 18,599 shares during the last quarter. Finally, Vanguard Group Inc. increased its position in agilon health by 1.3% during the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after purchasing an additional 371,537 shares during the last quarter.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.